Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells

Journal of Endocrinology

Volumn 210, Issue 1, 2011, Pages 105-115

  Zeybek, N Dilara ^a   Gulcelik, Nese Ersoz ^a   Kaymaz, F Figen ^a   Sarisozen, Can ^a   Vural, Imran ^a   Bodur, Ebru ^a   Canpinar, Hande ^a   Usman, Aydan ^a   Asan, Esin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; KI 67 ANTIGEN; ROSUVASTATIN;

ANTIBODY LABELING; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NICK END LABELING; PAPILLARY THYROID CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CARCINOMA, PAPILLARY; CASPASE 3; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; FLUOROBENZENES; G1 PHASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MICROSCOPY, ELECTRON, TRANSMISSION; OSMOLAR CONCENTRATION; PARATHYROID NEOPLASMS; PYRIMIDINES; SULFONAMIDES; TIME FACTORS; VACUOLES;

EID: 79960319733     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-10-0411     Document Type: Article

References (30)

1. Alegret M & Silvestre JS 2006 Pleiotropic effects of statins and related pharmacological experimental approaches. Methods and findings in experimental and clinical pharmacology 28 627-656.
2. Banasiak KJ, Xia Y & Haddad GG 2000 Mechanisms underlying hypoxiainduced neuronal apoptosis. Progress in Neurobiology 62 215-249.
3. Bifulco M 2008 Therapeutic potential of statins in thyroid proliferative disease. Nature Clinical Practice. Endocrinology and Metabolism 4 242-243.
4. Bifulco M, Laezza C & Aloj SM 1999 Inhibition of farnesylation blocks growth but not differentiation in FRTL-5 thyroid cells. Biochimie 81 287-290.
5. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C et al. 2006 Breast cancer growth pevention by statins. Cancer Research 66 8707-8714.
6. Cappelli C, Castellano M, Pirola I, Martino E, Gandossi E, Delbarba A, Salvi A & Rosei EA 2008 Reduced thyroid volume and nodularity in dyslipidemic patients on statin treatment. Clinical Endocrinology 68 16-21.
7. Chen JC, Wu ML, Huang KC & Lin WW 2008 HMG-Co Areductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression. Cardiovascular Research 80 138-150.
8. Gbelcová H, Lenícek M, Zelenka J, Knejzlík Z, Dvoráková G, Zadinová M, Poucková P, Kudla M, Balaz P, Ruml T et al. 2008 Differences in antitumor effects of various statins on human pancreatic cancer. International Journal of Cancer 122 1214-1221.
9. Goldstein JL & Brown MS 1990 Regulation of the mevalonate pathway. Nature 343 425-430.
10. Gozuacik D & Kimchi A 2007 Autophagy and cell death. Current Topics in Developmental Biology 78 217-245.
11. HawkMA, Cesen KT, Siglin JC, Stoner GD & Ruch RJ 1996 Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin. cancer Letters 109 217-222.
12. Heeres JT & Hergenrother PJ 2007 Poly(ADP-ribose) makes a date with death. Current Opinion in Chemical Biology 11 644-653.
13. Hornsby PJ & Didenko VV 2011 In situ ligation: a decade and a half of experience. Methods in Molecular Biology 682 49-63.
14. Hoyer-Hansen M & Jaattela M 2007 Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death and Differentiation 14 1576-1582.
15. Ikonen E 2006 Mechanisms for cellular cholesterol transport: defects and human disease. Physiological Reviews 86 1237-1261.
16. Katsiki N, Tziomalos K, Chatzizisis Y, Elisaf M & Hatzitolos AI 2009 Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental? Atherosclerosis 211 9-14
17. Kawata S, Nagase T, Yamasaki E, Ishiguro H & Matsuzawa Y 1994 Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2). British Journal of Cancer 69 1015-1020.
18. Levine B & Yuan J 2005 Autophagy in cell death: an innocent convict? Journal of Clinical Investigation 115 2679-2688
19. Lin YC, Lin JH, Chou CW, Chang YF, Yeh SH & Chen CC 2008 Statins increase p21 through inhibition of histone deacetylase activity and release of romoter-associated HDAC1/2. Cancer Research 68 2375-2383.
20. Mörck C, Olsen L, Kurth C, Persson A, Storm NJ, Svensson E, Jansson JO, Hellqvist M, Enejder A, Faergeman NJ et al. 2009 Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans. PNAS 106 18285-18290.
21. Parikh A, Childress C, Deitrick K, Lin Q, Rukstalis D & Yang W 2010 Statininduced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells. Prostate 70 971-981.
22. Sassano A & Platanias LC 2008 Statins in tumor suppression. Cancer Letters 260 11-19.
23. Scott RC, Juhász G & Neufeld TP 2007 Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death. Current Biology 17 1-1.
24. Sivaprasad U, Abbas T & Dutta A 2006 Differential efficacy of 3-hydroxy-3-methyl glutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Molecular Cancer Therapeutics 5 2310-2316.
25. Soldani C & Scovassi I 2002 Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7 321-328.
26. Thorburn A 2008 Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13 1-9.
27. Thornberry NA & Lazebnik Y 1998 Caspases: enemies within. Science 281 1312-1316.
28. Tsujimoto Y & Shimizu S 2005 Another way to die: autophagic programmed cell death. Cell Death and Differentiation 12 1528-1534.
29. Yorimitsu T, Nair U, Yang Z & Klionsky DJ 2006 Endoplasmic reticulum stress triggers autophagy. The Journal of Biological Chemistry 281 30299-30304.
30. Zhong W, Wang C, Chang T & Lee W 2003 Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibitor of protein geranylgeranylation and de novo protein synthesis. Endocrinology 144 3852-3859.